Fortrea Shares Drop 5.6% Amid Mixed Analyst Ratings

Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) experienced a significant decline of 5.6% in midday trading on Friday, dropping to as low as $16.58 before closing at $16.2850. This downturn followed a trading session where 170,352 shares changed hands, representing an 87% decrease from the average volume of 1,302,753 shares. The stock had previously ended the day at $17.25, signaling a challenging market position for the company.

Analyst Perspectives on Fortrea

Recent reports from various brokerages reveal a mixed outlook for Fortrea. On December 11, Citigroup upgraded the stock from a “neutral” rating to a “buy” rating, raising its price target from $12.00 to $21.00. Conversely, Wall Street Zen downgraded Fortrea from a “buy” to a “hold” rating on October 27. Wedbush also set a price target of $21.00 for the stock in its December 11 report, while Jefferies Financial Group adjusted its target from $7.00 to $9.50, maintaining a “hold” rating. Mizuho increased its target from $11.00 to $13.00, giving Fortrea a “neutral” rating.

The consensus among analysts indicates a cautious approach, with one analyst assigning a “strong buy,” two “buy,” nine “hold,” and one “sell” rating. According to MarketBeat, Fortrea currently holds an average rating of “hold” with a consensus price target of $13.28.

Financial Performance and Earnings Report

Fortrea announced its quarterly earnings on November 5, reporting $0.12 earnings per share (EPS), which fell short of the consensus estimate of $0.16 by $0.04. The company generated revenues of $701.30 million for the quarter, exceeding the expected $643.43 million. Despite the revenue growth, Fortrea recorded a negative net margin of 36.77% and a positive return on equity of 5.64%. Analysts predict that Fortrea will achieve an EPS of 0.51 for the current year.

Institutional Investors Adjust Holdings

The behavior of large institutional investors has also impacted Fortrea’s stock performance. AQR Capital Management LLC significantly increased its stake in Fortrea by 494.8% during the second quarter, acquiring an additional 5,419,842 shares, bringing its total holdings to 6,515,124 shares valued at approximately $31.73 million. Millennium Management LLC raised its position by 1,625.8% in the first quarter, now holding 3,499,220 shares worth around $26.42 million after buying 3,296,461 additional shares.

Other notable movements include Park West Asset Management LLC, which bought a new position valued at $18.58 million in the third quarter, and the Bank of Nova Scotia, which purchased a new stake worth $5.09 million in the second quarter. Corvex Management LP increased its holdings by 28.6%, now possessing 4,474,898 shares valued at approximately $33.79 million.

About Fortrea Holdings Inc.

Established as a spin-off from Thermo Fisher Scientific’s Pharma Services division in October 2023, Fortrea is a global contract development and manufacturing organization (CDMO). The company offers integrated solutions tailored for pharmaceutical and biotechnology firms, emphasizing the acceleration of drug development from early research through to commercial production. Fortrea’s services include analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging, catering to a diverse clientele in the industry.

As Fortrea navigates a challenging market landscape, investors and analysts alike will be closely monitoring its performance and strategic decisions in the coming months.